logo
  

Ingrid Andress Announces Headlining 'Feeling Things Tour' Of U.S., Europe

ladylike 072721 lt

Country music singer Ingrid Andress has announced an expansive U.S.-Europe tour spread across 2021 and 2022.

The "Feeling Things Tour" kicks off in Boston, Massachusetts, on September 27, and wraps up with a performance at Krosset in Oslo, Norway, on February 5.

Georgia Webster, who recently dropped her debut album First Goodbye, will join Andress as the opening performer on the U.S. leg of the trek.

Andress will also play as a supporting act as part of Dan + Shay's "The (Arena) Tour" this summer.

Tickets for The "Feeling Things Tour" will go on sale on July 29.

Tour Dates:

Sept. 27 -- Boston, Mass. @ Royale
Sept. 30 -- Madison, Wisc. @ Majestic Theatre
Oct. 5 -- Birmingham, Ala. @ Saturn
Oct. 6 -- Athens, Ga. @ Georgia Theater
Oct. 7 -- New York City @ Webster Hall
Oct. 11 -- Los Angeles, Calif. @ Troubadour
Nov. 6 -- Auburn, Ala. @ Jay and Susie Gogue Performing Arts Center
Nov. 15 -- Columbia, Mo. @ The Blue Note
Nov. 17 -- Chattanooga, Tenn. @ The Signal
Nov. 18 -- Nashville, Tenn. @ Brooklyn Bowl
Dec. 9 -- Richmond, Va. @ The National
Dec. 10 -- Pittsburgh, Pa. @ Stage AE
Jan. 18 -- Dublin, Ireland @ Whelan's
Jan. 19 -- Belfast, Northern Ireland, United Kingdom @ Limelight 1
Jan. 21 -- Glasgow, Scotland, United Kingdom @ Saint Luke's
Jan. 22 -- Manchester, England, United Kingdom @ Gorilla
Jan. 23 -- Birmingham, England, United Kingdom @ O2 Institute 3
Jan. 25 -- London, England, United Kingdom @ Scala
Jan. 27 -- Paris, France @ Le Pop Up Du Label
Jan. 29 -- Amsterdam, Netherlands @ Melkweg
Jan. 31 -- Berlin, Germany @ Privateclub
Feb. 1 -- Hamburg, Germany @ Nochtwache
Feb. 2 -- Copenhagen, Denmark @ Lille Vega
Feb. 3 -- Stockholm, Sweden @ Nalen Klubb
Feb. 5 -- Oslo, Norway @ Krosset

(Photo: Jess Williams)

For comments and feedback contact: editorial@rttnews.com

Entertainment News

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT